Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis
Stephen L. Pinkosky, Roger S. Newton, Emily A. Day, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 392

Showing 1-25 of 392 citing articles:

Targeting cancer metabolism in the era of precision oncology
Zachary E. Stine, Zachary T. Schug, Joseph M. Salvino, et al.
Nature Reviews Drug Discovery (2021) Vol. 21, Iss. 2, pp. 141-162
Open Access | Times Cited: 761
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
Nikolaus Marx, Massimo Federici, Katharina Schütt, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4043-4140
Open Access | Times Cited: 708
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
Kausik K. Ray, Harold Bays, Alberico L. Catapano, et al.
New England Journal of Medicine (2019) Vol. 380, Iss. 11, pp. 1022-1032
Open Access | Times Cited: 665
AMP-activated protein kinase: the current landscape for drug development
Gregory R. Steinberg, David Carling
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 7, pp. 527-551
Open Access | Times Cited: 561
AMPK as a Therapeutic Target for Treating Metabolic Diseases
Emily A. Day, Rebecca J. Ford, Gregory R. Steinberg
Trends in Endocrinology and Metabolism (2017) Vol. 28, Iss. 8, pp. 545-560
Closed Access | Times Cited: 554
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
Steven E. Nissen, A. Michael Lincoff, Danielle M. Brennan, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 15, pp. 1353-1364
Closed Access | Times Cited: 539
New insights into activation and function of the AMPK
Gregory R. Steinberg, D. Grahame Hardie
Nature Reviews Molecular Cell Biology (2022) Vol. 24, Iss. 4, pp. 255-272
Closed Access | Times Cited: 489
Lipid metabolism in cancer: New perspectives and emerging mechanisms
Lindsay A. Broadfield, Antonino Alejandro Pane, Ali Talebi, et al.
Developmental Cell (2021) Vol. 56, Iss. 10, pp. 1363-1393
Open Access | Times Cited: 417
Metabolic-associated fatty liver disease and lipoprotein metabolism
Jöerg Heeren, Ludger Scheja
Molecular Metabolism (2021) Vol. 50, pp. 101238-101238
Open Access | Times Cited: 409
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease
Anne C. Goldberg, Lawrence A. Leiter, Erik S.G. Stroes, et al.
JAMA (2019) Vol. 322, Iss. 18, pp. 1780-1780
Open Access | Times Cited: 392
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
Ulrich Laufs, Maciej Banach, G.B. John Mancini, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 7
Open Access | Times Cited: 361
Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
Christie M. Ballantyne, Maciej Banach, G.B. John Mancini, et al.
Atherosclerosis (2018) Vol. 277, pp. 195-203
Open Access | Times Cited: 359
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
Christie M. Ballantyne, Ulrich Laufs, Kausik K. Ray, et al.
European Journal of Preventive Cardiology (2019) Vol. 27, Iss. 6, pp. 593-603
Open Access | Times Cited: 296
Spatiotemporal Control of Acetyl-CoA Metabolism in Chromatin Regulation
Sharanya Sivanand, Isabella Viney, Kathryn E. Wellen
Trends in Biochemical Sciences (2017) Vol. 43, Iss. 1, pp. 61-74
Open Access | Times Cited: 289
Mendelian Randomization Study of ACLY and Cardiovascular Disease
Brian A. Ference, Kausik K. Ray, Alberico L. Catapano, et al.
New England Journal of Medicine (2019) Vol. 380, Iss. 11, pp. 1033-1042
Open Access | Times Cited: 284
Lipogenesis inhibitors: therapeutic opportunities and challenges
Battsetseg Batchuluun, Stephen L. Pinkosky, Gregory R. Steinberg
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 4, pp. 283-305
Open Access | Times Cited: 271
Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting
Josefin Soppert, Michael Lehrke, Nikolaus Marx, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 4-33
Open Access | Times Cited: 259
Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics
Yajun Duan, Ke Gong, Suowen Xu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 249
Lipid management in patients with chronic kidney disease
Charles J. Ferro, Patrick B. Mark, Mehmet Kanbay, et al.
Nature Reviews Nephrology (2018) Vol. 14, Iss. 12, pp. 727-749
Open Access | Times Cited: 208
ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review
Xiaojun Feng, Lei Zhang, Suowen Xu, et al.
Progress in Lipid Research (2019) Vol. 77, pp. 101006-101006
Closed Access | Times Cited: 192
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism
Carlotta Granchi
European Journal of Medicinal Chemistry (2018) Vol. 157, pp. 1276-1291
Open Access | Times Cited: 189
Optimizing Cholesterol Treatment in Patients With Muscle Complaints
Robert S. Rosenson, Steven K. Baker, Maciej Banach, et al.
Journal of the American College of Cardiology (2017) Vol. 70, Iss. 10, pp. 1290-1301
Open Access | Times Cited: 178
Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products
Dongdong Wang, Yang Yang, Yingnan Lei, et al.
Pharmacological Reviews (2019) Vol. 71, Iss. 4, pp. 596-670
Open Access | Times Cited: 175
Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia
Maciej Banach, P. Barton Duell, Antonio M. Gotto, et al.
JAMA Cardiology (2020) Vol. 5, Iss. 10, pp. 1124-1124
Open Access | Times Cited: 165
Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle
Koen H. G. Verschueren, Clément E. Blanchet, Jan Félix, et al.
Nature (2019) Vol. 568, Iss. 7753, pp. 571-575
Open Access | Times Cited: 161
Page 1 - Next Page

Scroll to top